Notably, both candidates are widely associated with BrCa risk6,12,13,24,25,26,27 and ranked within the top 25 of genes with the highest I-O target probability scores, yet little is known of the roles of LSP1 and TLR1 as genetic modifiers of the iTME. Here, TLR1 is linked to invasive breast carcinoma.